Congressional Stock Trades & Disclosures
Gilbert Ray Cisneros, Jr. is a U.S. Representative, a Democrat representing CA. As of September 2026, Quantellect has tracked 2,699 disclosed stock trades across 703 companies, representing $53.2M in disclosed transaction value, each filed publicly under the STOCK Act.

Trading summary
Gilbert Ray Cisneros, Jr.
- Q Score
- 84Strong
- Estimated profit results · 2Y
- Q Score rank
- #13 of 77
- Profitability rank · by return %: #42 of 77
- Profit win rate (2Y)
- 61%
- 545 of 893 priced buys up · unrealized
- vs S&P 500 (2Y)
- +2.9%
- +$267K estimated excess profit
- Latest disclosed trade
- Buy · MSB
- Traded 31 JUL 2026 · Disclosed 04 SEP 2026
About Gilbert Ray Cisneros, Jr.'s congressional trading
Since January 2019, the House member representing California's 31st District has filed disclosures covering 2,633 separate securities transactions. The most recent filing, covering transactions executed through June 30, 2026, shows 17 equity transactions on that final trading day across technology, healthcare, industrials, financials and other sectors, submitted to the House Clerk two days later. That cadence, hundreds of disclosed transactions a year spread across a very wide roster of names, is the defining feature of this trading record rather than any single large transaction.
Every one of the 2,633 transactions in the disclosure data carries the attribution code SELF, meaning the data assigns the activity to Cisneros rather than to a spouse, dependent child, joint attribution, or an unidentified filer. The filings do not break out any activity under a different attribution category. The most recent official filing also identifies 150 Main Street Trust and Bank of America or Wells Fargo Advisors in its account details, so the SELF code should not be read as evidence that Cisneros personally directed each transaction (disclosure).
Trading Frequency and Recent Activity
The transaction history splits fairly evenly between buying and selling: 1,498 purchases against 1,114 sales, with 21 transactions coded as another type, out of 2,633 total. Disclosed activity spans four calendar years in the data set, 2019, 2020, 2025 and 2026, with 2025 alone accounting for 827 transactions (492 purchases, 332 sales, 3 other) and 2026 already at 638 transactions (382 purchases, 255 sales, 1 other) through June 30. 2020 recorded 720 transactions (400 purchases, 311 sales, 9 other), and 2019, the first year in the record, recorded 448 (224 purchases, 216 sales, 8 other).
The July 2, 2026 filing illustrates the pattern well. On June 30, the filing lists purchases in Texas Roadhouse, Descartes Systems Group, Argan, Texas Capital Bancshares, Microchip Technology, Boot Barn, Cadre Holdings, CECO Environmental, Cytokinetics and HealthEquity, alongside partial or full sales in SoftBank Group, Credo Technology Group, Sterling Infrastructure, RBC Bearings, CBIZ, Broadcom and Semtech. The same filing records a $100,001 to $250,000 purchase of Los Angeles municipal tax and revenue anticipation notes on June 24. Most individual equity transactions in this filing fall in the $1,001 to $15,000 disclosure range, but it also includes larger disclosed ranges: a $50,001 to $100,000 purchase of Eli Lilly on June 10 and a $500,001 to $1,000,000 sale of Mount San Jacinto Community College District bonds on June 2 (disclosure). Separately, the June 8 filing includes a $250,001 to $500,000 purchase of New York City Transitional Finance Authority bonds on May 29 (disclosure). Those filings illustrate a mix of frequent small equity transactions and occasional larger municipal-bond transactions. The STOCK Act sets a deadline no later than 45 days after a reportable transaction; the June 30 transactions were disclosed on July 2, and the cited May 29 transactions were disclosed on June 8.
Sector Activity and Frequently Disclosed Names
Across the full transaction history, disclosed activity concentrates most heavily in Information Technology (468 transactions), followed by an Unknown/unclassified sector (430), Health Care (379), Industrials (318), Financials (274), Consumer Discretionary (246), Consumer Staples (121), Real Estate (113), Communication Services (95), Materials (92), Energy (73), Utilities (23) and a single transaction tagged simply Technology. Information Technology's lead is consistent with a trading pattern touching a large number of software, hardware and semiconductor names repeatedly over time.
By transaction count, GoDaddy is the most frequently disclosed security, appearing in 28 transactions (13 purchases, 15 sales) through June 16, 2026, a domain-registration and small-business software platform that also sells hosting, security and payments tools. Amazon.com and CoStar Group each appear 20 times; DoorDash appears 20 times as well but skews heavily toward buying, 18 purchases against 2 sales. Flex shows the opposite pattern, 4 purchases against 14 sales across 18 transactions. W. R. Berkley, the commercial-lines insurer, appears in 16 transactions that are all sales, while FirstService, the residential property manager, and LPL Financial Holdings, the independent broker-dealer platform, each appear in transactions that are entirely purchases (11 and 10, respectively). Boston Scientific, NVIDIA, UnitedHealth Group, Microsoft, Verisk Analytics, ConAgra Brands, Intuit, MercadoLibre and Palantir Technologies round out the next tier of most-frequently-disclosed names, each showing double-digit transaction counts with a mix of buying and selling.
A few of the frequently disclosed names sit further back in the calendar. CTLT, for example, ranks among the most-disclosed tickers by count, but its last recorded transaction in this data set dates to September 2020, meaning its place in the frequency ranking reflects historical rather than recent activity. Elsewhere the record shows transaction activity through mid-2026 in familiar large-cap names, including Apple, Microsoft, Tesla and Coinbase Global, alongside smaller, more specialized companies such as HealthEquity (health savings account administration), Descartes Systems Group (logistics and supply-chain software) and Cytokinetics (a biopharmaceutical developer of cardiac muscle therapies), each of which appears in the most recent filing.
Cisneros has a Quantellect Score of 84, placing him in the "strong" tier and ranking 13th in a 76-member scored cohort as of August 21, 2026, based on the current formula version. For context, as of August 22, 2026, 276 of 537 sitting members of Congress had no disclosed transactions in the data.
Disclosure and Methodology Notes
This profile is built entirely from Cisneros's official periodic transaction reports filed with the U.S. House of Representatives, as required under the STOCK Act, and cross-referenced against the House Committee on Ethics financial disclosure instruction guide. Members of Congress and their spouses and dependent children are required to disclose transactions exceeding applicable thresholds in stocks, bonds and other securities, generally within 45 days. Disclosed dollar amounts are reported in ranges, not exact figures, and this profile reports only those ranges. Figures described here reflect transaction-level filings only and do not establish whether any security remained owned after a reported transaction. Data reflects the filings included in the packet and may not include newer disclosures that have not yet been processed.
Trading activity
Estimated trading profits
The 2Y view uses the same buy-only, priced trade inputs as the Q Score.
Based on 1,451 of 1,530 disclosed buys with pricing coverage.
Jan 18, 2019 to Sep 4, 2026
No priced buy disclosures in this window.
Based on 81 of 81 disclosed buys with pricing coverage.
Jun 4, 2026 to Sep 4, 2026
Based on 242 of 245 disclosed buys with pricing coverage.
Mar 4, 2026 to Sep 4, 2026
Based on 722 of 736 disclosed buys with pricing coverage.
Sep 4, 2025 to Sep 4, 2026
Based on 893 of 912 disclosed buys with pricing coverage.
Sep 8, 2024 to Sep 8, 2026
Based on 893 of 912 disclosed buys with pricing coverage.
Sep 4, 2023 to Sep 4, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Where the Money Sits
share of disclosed trades · top sectors
Periodic Transaction Report filings
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
MSBMesabi Trust | Buy | $15,001 - $50,000 | 31 JUL 2026 | $21.99 | +8.69% |
ALKSAlkermes Plc | Buy | $15,001 - $50,000 | 30 JUL 2026 | $50.03 | -7.86% |
PRAXPraxis Precision Medicines Inc | Buy | $1,001 - $15,000 | 30 JUL 2026 | $307.75 | +14.32% |
CRNXCrinetics Pharmaceuticals Inc | Sell | $15,001 - $50,000 | 30 JUL 2026 | $83.63 | +1.58% |
ADBEAdobe Systems Incorporated | Sell | $1,001 - $15,000 | 24 JUL 2026 | $225.11 | +18.39% |
BABAAlibaba Group Holding Ltd | Sell | $100,001 - $250,000 | 24 JUL 2026 | $112.14 | +0.98% |
NSANational Storage Affiliates Trust | Exchange | $15,001 - $50,000 | 23 JUL 2026 | $43.41 | +0.00% |
VIAVViavi Solutions Inc | Sell | $1,001 - $15,000 | 21 JUL 2026 | $43.02 | -18.97% |
SMTCSemtech Corporation | Sell | $1,001 - $15,000 | 21 JUL 2026 | $137.84 | +7.29% |
FDXFedEx Corporation | Sell | $1,001 - $15,000 | 21 JUL 2026 | $315.19 | +2.33% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Gilbert Ray Cisneros, Jr. congressional trading FAQ
Can Gilbert Ray Cisneros, Jr. legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Gilbert Ray Cisneros, Jr.'s disclosures so the public can review them.
Where does Quantellect get Gilbert Ray Cisneros, Jr.'s trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Gilbert Ray Cisneros, Jr.'s stock trades?
Quantellect tracks every stock trade Gilbert Ray Cisneros, Jr. discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Gilbert Ray Cisneros, Jr. disclosed?
Quantellect has tracked 2,699 disclosed trades by Gilbert Ray Cisneros, Jr. across 703 companies.
Which stocks does Gilbert Ray Cisneros, Jr. trade most?
Gilbert Ray Cisneros, Jr.'s most frequently disclosed positions are GDDY (28 disclosed trades), AMZN (20 disclosed trades), CSGP (20 disclosed trades), DASH (20 disclosed trades), NVDA (19 disclosed trades), and BSX (18 disclosed trades), followed by FLEX, UNH, MSFT, and WRB. The full list of companies and individual filings is shown on this page.
Which sectors does Gilbert Ray Cisneros, Jr. invest in?
Technology is the heaviest sector in Gilbert Ray Cisneros, Jr.'s classified disclosures, covering 528 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.
What was Gilbert Ray Cisneros, Jr.'s most recent stock disclosure?
Gilbert Ray Cisneros, Jr. most recently bought Mesabi Trust (MSB) in July 2026, according to public STOCK Act filings tracked by Quantellect.
What is Gilbert Ray Cisneros, Jr.'s Quantellect Score?
Gilbert Ray Cisneros, Jr. has a Quantellect Score of 84 out of 100 (Strong). The score ranks members by the estimated unrealized results of their disclosed buys over the last 24 months, weighting estimated total profit, profit versus the S&P 500, and win rate. It is a descriptive research signal, not investment advice or an allegation of unlawful trading.
How much has Gilbert Ray Cisneros, Jr. made trading stocks?
Quantellect estimates Gilbert Ray Cisneros, Jr.'s disclosed buys show an estimated unrealized profit of $1.2 million over the trailing 12 months, based on priced disclosed buy transactions through September 4, 2026. This is an estimate and does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. It is descriptive research, not investment advice or an allegation of wrongdoing.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.











